Pre-treatment DPYD genetic testing for patients who are prescribed chemotherapy involving fluoropyrimidines – SHTG Assessment

Harbour J
Record ID 32018000858
English
Details
Project Status: Completed
Year Published: 2020
Requestor: NHS National Services Scotland
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Scotland, United Kingdom
MeSH Terms
  • Pharmacogenomic Testing
  • Genetic Testing
  • Antineoplastic Combined Chemotherapy Protocols
  • Pyrimidines
  • Neoplasms
  • Precision Medicine
Keywords
  • DYPD
  • dihydropyrimidine dehydrogenase
  • fluoropyrimidines
Contact
Organisation Name: Scottish Health Technologies Group
Contact Address: Scottish Health Technologies Group, Delta House, 50 West Nile Street, Glasgow, G1 2NP Tel: 0141 225 6998
Contact Name: his.shtg@nhs.scot
Contact Email: his.shtg@nhs.scot
Copyright: Healthcare Improvement Scotland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.